Clinical Trials › NCT00716066
Active, Not RecruitingPhase 2
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
Sponsored by Fred Hutchinson Cancer Center
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 53
Target enrollment
2
U.S. states
Jun 2008
Start date
Jan 2030
Expected completion
Interventions / Treatments
Anti-Thymocyte GlobulinAutologous Hematopoietic Stem Cell TransplantationCarmustineCytarabineEtoposideLaboratory Biomarker AnalysisMelphalanPeripheral Blood Stem Cell TransplantationPrednisoneSyngeneic Bone Marrow Transplantation
Conditions studied
Multiple Sclerosis TransplantMS Stem Cell TransplantMultiple Sclerosis Stem Cell Transplant
Where this trial is running (3 sites)
Washington2 sites
Seattle · Seattle
Colorado1 site
Denver
Participating MS centers on MS Buddy (2)
UW Medicine Multiple Sclerosis Center
Seattle, WA
Seattle, WA
Swedish Neuroscience Institute MS Center
Seattle, WA
Seattle, WA
MS centers in Washington
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Washington centersMore Phase 2 trials
Browse all Phase 2 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
